Fibrinogen gene regulation

Thrombosis and Haemostasis

Volumn 108, Issue 3, 2012, Pages 419-426

  Fish, Richard J ^a   Neerman Arbez, Marguerite ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Department of Surgery   (Switzerland)

Author keywords

Enhancer; Fibrinogen; Gene regulation; miRNA; Promoter

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CRYOPYRIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBRINOGEN; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; MICRORNA 29; MITOGEN ACTIVATED PROTEIN KINASE P38; POLYPEPTIDE; PROPIONYL COENZYME A CARBOXYLASE; STAT3 PROTEIN;

ACUTE PHASE RESPONSE; ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME 4; ENHANCER REGION; FIBRINOGEN BLOOD LEVEL; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION;

ACUTE-PHASE REACTION; AFIBRINOGENEMIA; ANIMALS; CYTOKINES; ENHANCER ELEMENTS, GENETIC; FIBRINOGEN; FORECASTING; GENE EXPRESSION REGULATION; GENOTYPE; GLUCOCORTICOIDS; HEPATOCYTES; HUMANS; MICE; MICRORNAS; MODELS, GENETIC; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84865819454     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-04-0273     Document Type: Article

References (89)

1. Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem 1984; 53:195-229.
2. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Hae-most2005;3: 1894-1904.
3. Standeven KF, Ariens RA, Grant PJ. The molecular physiology and pathology of fibrin structure/function. Blood Rev 2005; 19: 275-288.
4. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000; 96: 3772-3778.
5. Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998; 273: 7554-7559.
6. Clark RA, Lanigan JM, DellaPelle P, et al Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79:264-269.
7. Donaldson DJ, Mahan JT, Amrani D, et al Fibrinogen-mediated epidermal cell migration: structural correlates for fibrinogen function. J Cell Sci 1989; 94:101-108.
8. Kant JA, Fornace AJ, Jr., Saxe D, et al Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985; 82: 2344-2348.
9. de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 2010; 36: 7-17.
10. de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders. Semin Thromb Hemost 2009; 35: 356-366.
11. Danesh J, Collins R, Appleby P,et al Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc 1998; 279: 1477-1482.
12. Danesh J, Lewington S, Thompson SG, et al Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005; 294: 1799-1809.
13. Lowe GD, Rumley A. Fibrinogen and its degradation products as thrombotic risk factors. Ann NY Acad Sci 2001; 936: 560-565.
14. Kaptoge S, White IR, Thompson SG, et al Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 2007;166:867-879.
15. Woodward M, Rumley A, Welsh Petal. A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. J Thromb Haemost 2007; 5: 1795-1800.
16. Welsh P, Woodward M, Rumley A, etal. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haema-tol 2008; 141: 852-861.
17. Kamphuisen PW, Eikenboom JC, Vos HL, et al Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not causedby acute phase reactions. Thromb Haemost 1999; 81: 680-683.
18. Machlus KR, Cardenas JC, Church FC, et al Causal relationship between hyper-fibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 2011; 117:4953-4963.
19. Green FR. Fibrinogen polymorphisms and atherothrombotic disease. Ann NY Acad Sci 2001; 936: 549-559.
20. Crabtree GR, Kant JA. Molecular cloning of cDNA for the alpha, beta, and gamma chains of rat fibrinogen. A family of coordinately regulated genes. J Biol Chem 1981;256:9718-9723.
21. Crabtree GR, Kant JA. Coordinate accumulation of the mRNAs for the alpha, beta, and gamma chains of rat fibrinogen following defibrination. J Biol Chem 1982; 257: 7277-7279.
22. Grieninger G, Hertzberg KM, Pindyck J. Fibrinogen synthesis in serum-free hepatocyte cultures: stimulation by glucocorticoids. Proc Natl Acad Sci USA 1978; 75: 5506-5510.
23. Fuller GM, Otto JM, Woloski BM, et al The effects of hepatocyte stimulating factor on fibrinogen biosynthesis in hepatocyte monolayers. J Cell Biol 1985; 101: 1481-1486.
24. Ritchie DG, Fuller GM. Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein. Ann NY Acad Sci 1983; 408:490-502.
25. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
26. Fuller GM, Zhang Z. Transcriptional control mechanism of fibrinogen gene expression. Ann NY Acad Sci 2001; 936:469-479.
27. Courtois G, Morgan JG, Campbell LA, et al Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science 1987; 238: 688-692.
28. Hu CH, Harris JE, Davie EW, et al Characterization of the 5'-flanking region of the gene for the alpha chain of human fibrinogen. J Biol Chem 1995; 270: 28342-28349.
29. Dalmon J, Laurent M, Courtois G. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol 1993; 13: 1183-1193.
30. Mizuguchi J, Hu CH, Cao Z, et al Characterization of the 5'-flanking region of the gene for the gamma chain of human fibrinogen. J Biol Chem 1995; 270: 28350-28356.
31. Morgan JG, Courtois G, Fourel G, et al Sp 1, a CAAT-binding factor, and the ade-novirus major late promoter transcription factor interact with functional regions of the gamma-fibrinogen promoter. Mol Cell Biol 1988; 8: 2628-2637.
32. Huber P, Laurent M, Dalmon J. Human beta-fibrinogen gene expression. Upstream sequences involved in its tissue specific expression and its dexamethasone and interleukin 6 stimulation. J Biol Chem 1990; 265: 5695-5701
33. Anderson GM, Shaw AR, Shafer JA. Functional characterization of promoter elements involved in regulation of human B beta-fibrinogen expression. Evidence for binding of novel activator and repressor proteins. J Biol Chem 1993; 268: 22650-2265.
34. Zhang Z, Fuentes NL, Fuller GM. Characterization of the IL-6 responsive elements in the gamma fibrinogen gene promoter. J Biol Chem 1995; 270: 24287-24291.
35. Liu Z, Fuller GM. Detection of a novel transcription factor for the A alpha fibrinogen gene in response to interleukin-6. J Biol Chem 1995; 270: 7580-7586
36. Liu Z, Fuentes NL, Jones SA, et al A unique transcription factor for the A alpha fibrinogen gene is related to the mitochondrial single-stranded DNA binding protein P16. Biochemistry 1997; 36: 14799-14806.
37. Zhang Z, Fuller GM. Interleukin lbeta inhibits interleukin 6-mediated rat gamma fibrinogen gene expression. Blood 2000; 96: 3466-3472.
38. Albrecht U, Yang X, Asselta R, et al Activation of NF-kappaB by IL-lbeta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene. Cell Signal 2007; 19:1866-1878.
39. Otto JM, Grenett HE, Fuller GM. The coordinated regulation of fibrinogen gene transcription by hepatocyte-stimulating factor and dexamethasone. J Cell Biol 1987; 105: 1067-1072.
40. Zhang Z, Jones S, Hagood JS, et al STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem 1997; 272: 30607-30610.
41. Asselta R, Duga S, Modugno M, et al Identification of a glucocorticoid response element in the human gamma chain fibrinogen promoter. Thromb Haemost 1998;79:1144-1150.
42. Dittrich A, Khouri C, Sackett SD, et al Glucocorticoids increase interleukin-6-de-pendent gene induction by interfering with the expression of the suppressor of cy-tokine signaling 3 feedback inhibitor. Hepatology 2012; 55: 256-266.
43. 1 flanking regions. Proc Natl Acad Sci USA 1984; 81: 2313-2316.
44. Huber P, Dalmon J, Courtois G, et al Characterization of the 5'-flanking region for the human fibrinogen beta gene. Nucleic Acids Res 1987; 15: 1615-1625.
45. Roy S, Overton O, Redman C. Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. J Biol Chem 1994; 269:691-695.
46. Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265: 6389-6393.
47. Rezaee F, Maas A, Verheijen JH, et al Increased hepatic fibrinogen Bbeta-gene transcription is not enough to increase plasma fibrinogen levels. A transgenic mouse study. Thromb Haemost 2001; 85:1025-1030.
48. Suh TT, Holmback K, Jensen NJ, et al Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 1995; 9: 2020-2033.
49. Bremner WF, Sothern RB, Kanabrocki EL, et al Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J 2000; 139:164-173.
50. Sakao E, Ishihara A, Horikawa K, et al Two-peaked synchronization in day/night expression rhythms of the fibrinogen gene cluster in the mouse liver. J Biol Chem 2003; 278: 30450-30457.
51. Ahituv N, Prabhakar S, Poulin F, et al Mapping cis-regulatory domains in the human genome using multi-species conservation of synteny. Hum Mol Genet 2005; 14: 3057-3063.
52. Dermitzakis ET, Reymond A, Antonarakis SE. Conserved non-genic sequences -an unexpected feature of mammalian genomes. Nat Rev Genet 2005; 6:151-157.
53. Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M, et al In vivo enhancer analysis of human conserved non-coding sequences. Nature 2006; 444: 499-502.
54. Fort A, Fish RJ, Attanasio C, et al A liver enhancer in the fibrinogen gene cluster. Blood 2011; 117:276-282.
55. Schmidt D, Wilson MD, Ballester B, et al Five-vertebrate ChlP-seq reveals the evolutionary dynamics of transcription factor binding. Science 2010; 328: 1036-1040.
56. Kuo CJ, Conley PB, Chen L, et al A transcriptional hierarchy involved in mammalian cell-type specification. Nature 1992; 355: 457-461.
57. Birney E, Stamatoyannopoulos JA, Dutta A, et al Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447: 799-816.
58. Visel A, Blow M J, Li Z, et al ChlP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457: 854-858.
59. Kasper LH, Fukuyama T, Biesen MA, et al Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol Cell Biol 2006; 26: 789-809.
60. Vo N, Goodman RH. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 2001; 276:13505-13508.
61. Ban N, Yamada Y, Someya Y, et al Hepatocyte nuclear factor-lalpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes 2002; 51: 1409-1418.
62. Erickson RL, Hemati N, Ross SE, et al p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. J Biol Chem 2001; 276: 16348-16355.
63. Mink S, Haenig B, Klempnauer KH. Interaction and functional collaboration of p300 and C/EBPbeta. Mol Cell Biol 1997; 17: 6609-6617.
64. Nakashima K, Yanagisawa M, Arakawa H, et al Synergistic signaling in fetal brain by STAT3-Smadl complex bridged by p300. Science 1999; 284:479-482.
65. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-233.
66. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011; 12: 99-110.
67. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610.
68. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39 (Database issue): D152-157.
69. Fort A, Borel C, Migliavacca E, et al Regulation of fibrinogen production by microRNAs. Blood 2010; 116:2608-2615.
70. Hatziapostolou M, Polytarchou C, Aggelidou E, et al An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011; 147: 1233-1247.
71. Brock M, Trenkmann M, Gay RE, et al Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microR-NA cluster 17/92 pathway. Circ Res 2009; 104: 1184-1191.
72. Brock M, Trenkmann M, Gay RE, et al MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J Biol Chem 2011; 286: 40142-40150.
73. Reiner AP, Carty CL, Carlson CS, et al Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Thromb Haemost2006;4: 1279-1287.
74. Danik JS, Pare G, Chasman DI, et al Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study. Circ Cardiovasc Genet 2009; 2: 134-141.
75. Dehghan A, Yang Q, Peters A, et al Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet 2009; 2:125-133.
76. Thomas A, Lamlum H, Humphries S, et al Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (Haelll), C/T-148 (Hindlll/Alul), T/G+1689 (Avail), and Bell (beta-fibrinogen) andTaql (alpha-fibrinogen), and their detection by PCR. Hum Mutat 1994; 3: 79-81.
77. de Maat MP, Kastelein JJ, Jukema JW, et al -455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vase Biol 1998; 18: 265-271.
78. Green F, Hamsten A, Blomback M, et al The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-920.
79. Thomas AE, Green FR, Kelleher CH, et al Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65:487-490.
80. van't Hooft FM, von Bahr SJ, Silveira A, et al Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vase Biol 1999; 19:3063-3070.
81. Brown ET, Fuller GM. Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. Blood 1998; 92: 3286-3293.
82. Verschuur M, de Jong M, Felida L, et al A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphism. J Biol Chem 2005;280:16763-16771.
83. de Wit E, de Laat W. A decade of 3C technologies: insights into nuclear organization. Genes Dev 2012; 26:11-24.
84. Dekker J, Rippe K, Dekker M, et al Capturing chromosome conformation. Science 2002; 295: 1306-1311.
85. Li G, Ruan X, Auerbach RK, et al Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012; 148: 84-98.
86. Cook PR. The organization of replication and transcription. Science 1999; 284: 1790-1795.
87. Kim TK, Hemberg M, Gray JM, et al Widespread transcription at neuronal activity-regulated enhancers. Nature 2010; 465: 182-187.
88. Birnbaum RY, Clowney EJ, Agamy O, et al Coding exons function as tissue-specific enhancers of nearby genes. Genome Res 2012; epub ahead of print.
89. Fish RJ, Neerman-Arbez M. A novel regulatory element between the human FGA and FGG genes. Thromb Haemost 2012; 108: 427-434.